Title : HGF/c-MET pathway contributes to cisplatin-mediated PD-L1 expression in hepatocellular carcinoma.

Pub. Date : 2021 Dec

PMID : 34486197






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HGF/c-MET pathway contributes to cisplatin-mediated PD-L1 expression in hepatocellular carcinoma. Cisplatin CD274 molecule Homo sapiens
2 Cisplatin has been reported to promote the expression of PD-L1 in some cancer cells. Cisplatin CD274 molecule Homo sapiens
3 However, the underlying mechanism through which PD-L1 is transcriptionally regulated by cisplatin in HCC cells remains largely unknown. Cisplatin CD274 molecule Homo sapiens
4 In the present study, we found that the expression of HGF, p-Akt, p-ERK, and PD-L1 was increased in cisplatin-treated SNU-368 and SNU-739 cells. Cisplatin CD274 molecule Homo sapiens
5 Moreover, Inhibition of HGF/c-MET, PI3K/Akt, and MEK/ERK signaling pathways can dramatically block cisplatin or HGF-induced PD-L1 expression in SNU-368 and SNU-739 cells. Cisplatin CD274 molecule Homo sapiens
6 Taken together, our study suggested that HGF/c-Met axis-induced the activation of PI3K/Akt and MEK/ERK pathways contributes to cisplatin-mediated PD-L1 expression. Cisplatin CD274 molecule Homo sapiens